郭俊平. 106例静脉滴注莫西沙星致不良反应的分析[J]. 实用临床医药杂志, 2019, 23(21): 108-110. DOI: 10.7619/jcmp.201921031
引用本文: 郭俊平. 106例静脉滴注莫西沙星致不良反应的分析[J]. 实用临床医药杂志, 2019, 23(21): 108-110. DOI: 10.7619/jcmp.201921031
GUO Junping. Analysis of adverse reactions caused by intravenous infusion of moxifloxacin in 106 cases[J]. Journal of Clinical Medicine in Practice, 2019, 23(21): 108-110. DOI: 10.7619/jcmp.201921031
Citation: GUO Junping. Analysis of adverse reactions caused by intravenous infusion of moxifloxacin in 106 cases[J]. Journal of Clinical Medicine in Practice, 2019, 23(21): 108-110. DOI: 10.7619/jcmp.201921031

106例静脉滴注莫西沙星致不良反应的分析

Analysis of adverse reactions caused by intravenous infusion of moxifloxacin in 106 cases

  • 摘要:
      目的  分析本院5年的静脉滴注莫西沙星致不良反应的发生情况和影响因素。
      方法  收集接受莫西沙星静脉滴注抗菌治疗的患者,分析其不良反应发生情况。对患者性别、年龄、不良反应累及系统或器官和临床表现、不良反应发生率进行描述性统计,并对不良反应发生率与性别、年龄和药品类别的相关性进行Pearson's卡方检验。
      结果  6 222例患者中,有106例发生不良反应,发生率为1.70%,其中严重不良反应7例。不良反应主要累及消化系统、皮肤、神经精神系统,占比依次为32.08%、28.30%、20.75%。本组发生QTc间期延长2例,变态反应1例。静脉滴注莫西沙星致不良反应的发生率与高、中、低年龄分层和原研药、仿制药的药品类别无关,与性别存在显著相关性(P < 0.01)。
      结论  临床使用莫西沙星时,医务人员应问询并掌握患者病史和氟喹诺酮类药物用药史信息,加强用药监控,以提高莫西沙星用药的合理性和安全性。

     

    Abstract:
      Objective  To analyze the incidence and influencing factors of adverse reactions caused by intravenous infusion of moxifloxacin in our hospital within 5 years.
      Methods  Patients who received antibiotic therapy with moxifloxacin intravenous infusion were enrolled, and the occurrence of adverse reactions was analyzed. Descriptive statistic analysis were performed on the patient's gender, age, adverse reactions involving system or organ and clinical manifestations, and adverse reactions. Pearson′s chi-square test was performed on the correlation between adverse reaction rates and gender, age, and drug classes.
      Results  Of the 6 222 patients, 106 had adverse reactions, with its incidence of 1.70%, among whom 7 occurred serious adverse reactions. Adverse reactions mainly involved in the digestive system, skin, and neuropsychiatric system, accounting for 32.08%, 28.30%, and 20.75%, respectively. There were 2 cases with QTc interval prolonging and 1 case with allergic reaction in this group. The incidence of adverse reactions caused by intravenous infusion of moxifloxacin was not associated with elder, middle and young age, drug types of original drugs and generic drugs, but showed significant correlation with gender (P < 0.01).
      Conclusion  Medical staff should inquire and master the patient′s medical history and history of fluoroquinolone medication when using moxifloxacin, strengthen drug monitoring so as to improve its rationality and safety.

     

/

返回文章
返回